Off-label medication use remains an indispensable practice driven by unmet clinical needs, prompting worldwide regulatory efforts to ensure safety and encourage further research.
Systematic Review
Off-label medication use remains an indispensable practice driven by unmet clinical needs, requiring ongoing regulatory efforts to ensure patient safety.
Off-label use of drugs is widely known as unapproved use of approved drugs, and it can be perceived as a relatively simple concept. Even though it has been in existence for many years, prescribing and dispensing of drugs in an off-label regimen is still a current issue, triggered especially by unmet clinical needs. Several therapeutic areas require off-label approaches; therefore, this practice is challenging for prescribing physicians. Meanwhile, the regulatory agencies are making efforts in order to ensure a safe practice. The present paper defines the off-label concept, and it describes its regulation, together with several complex aspects associated with clinical practices regarding rare diseases, oncology, pediatrics, psychiatry therapeutic areas, and the safety issues that arise. A systematic research of the literature was performed, using terms, such as "off-label", "prevalence", "rare diseases", "oncology", "psychiatry", "pediatrics", and "drug repurposing". There are several reasons for which off-label practice remains indispensable in the present; therefore, efforts are made worldwide, by the regulatory agencies and governmental bodies, to raise awareness and to ensure safe practice, while also encouraging further research.
Rusz et al. (Mon,) conducted a systematic review in Off-label medication use. Off-label medication was evaluated. Off-label medication use remains an indispensable practice driven by unmet clinical needs, prompting worldwide regulatory efforts to ensure safety and encourage further research.